© Copyright Acquisition International 2026 - All Rights Reserved.

Article Image - Bio-Techne Corporation Agrees to Acquire Zephyrus Biosciences, Inc.
Posted 21st March 2016

Bio-Techne Corporation Agrees to Acquire Zephyrus Biosciences, Inc.

Bio-Techne Corporation (NASDAQ: TECH) announced today that it has completed the acquisition of Zephyrus Biosciences.

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

Bio-Techne Corporation Agrees to Acquire Zephyrus Biosciences, Inc.
Image

Bio-Techne Corporation (NASDAQ: TECH) announced today that it has completed the acquisition of Zephyrus Biosciences.  Zephyrus Biosciences will be integrated into the Protein Platforms Division of Bio-Techne.

Zephyrus Biosciences provides research tools to enable protein analysis at the single cell level. Addressing the burgeoning single cell analysis market, Zephyrus’s first product, the Z1™ System, enables western blotting on individual cells for the first time. Researchers will utilize Zephyrus’s products to gain new insights into the biology of cancer, stem cells, neurology, and human disease and development. Zephyrus spun out from Dr. Amy Herr’s laboratory at U.C. Berkeley in 2013 and has affiliations with QB3, StartX, CLSI/BayBio, and Berkeley SkyDeck. 

Charles R. Kummeth, President and Chief Executive Officer of Bio-Techne, said:

“The acquisition of Zephyrus demonstrates our continued interest in western blotting, a vital technique in protein identification and characterization. This new technology brings this technique to the single cell level, allowing us to address both homogenous sample populations with our Simple Western™ platforms and now heterogeneous populations at the single cell level with Zephyrus and the Z1 System. We are very excited to bring the Zephyrus products and team onboard.”

Zephyrus co-founder and Chief Executive Officer Kelly Gardner, Ph.D. added:

“We are excited to join Bio-Techne and bring our system into the ProteinSimple family of products. This deal provides an excellent path forward for commercialization of the single cell Western Blot (scWestern Blot) technology.  The market reach of Bio-Techne will enable Zephyrus to rapidly reach the broad market of researchers who need to study proteins at the single cell level.”

Dr. Gardner and other members of the Zephyrus team will remain in place following the closing.

Categories: M&A


You Might Also Like
Read Full PostRead - Eye Icon
Institutional Investors Shy Away from Hacked Businesses
Finance
16/04/2015Institutional Investors Shy Away from Hacked Businesses

A cyber attack could cost a business its investor backing, according to new figures revealed today. A survey of Global institutional investors by KPMG found that 79 percent of investors would be discouraged from investing in a business that has been hacked.

Read Full PostRead - Eye Icon
Streamlining Your Online Payment Process: A New Era of Online Transactions
Finance
30/03/2023Streamlining Your Online Payment Process: A New Era of Online Transactions

When discussing streamlining, we mean ways to make your payment transactions more convenient. The number one benefit of streamlining is to make your customers happy, as they will be able to pay quickly and efficiently.

Read Full PostRead - Eye Icon
Banks Among the Worst at Blaming Customers When Things Go Wrong
Finance
26/05/2015Banks Among the Worst at Blaming Customers When Things Go Wrong

The traditional mantra for successful businesses ‘the customer is always right’ is under threat according to new research by alldayPA.

Read Full PostRead - Eye Icon
Merkle’s Acquisition of Periscopix
M&A
21/05/2015Merkle’s Acquisition of Periscopix

Merkle's Acquisition of Periscopix

Read Full PostRead - Eye Icon
Oddfellows Society Takes on £45m of Druids Sheffield Business
Finance
26/03/2015Oddfellows Society Takes on £45m of Druids Sheffield Business

The Oddfellows Friendly Society is to take over the assets of the Druids Sheffield Friendly Society, including its Child Trust Fund ISA and life assurance business. The deal will increase the Oddfellows’ assets by £45m to over £460m and result in a combine

Read Full PostRead - Eye Icon
Answering All the Right Questions for Distribution Network Optimization
Innovation
12/05/2016Answering All the Right Questions for Distribution Network Optimization

In today’s rapidly changing distribution environment, it’s critical for businesses to look inside and outside the box, in order to optimize the entire network as well as warehouse labor and capacity.

Read Full PostRead - Eye Icon
Is Call Tracking Your Marketing Saviour?
Innovation
09/01/2023Is Call Tracking Your Marketing Saviour?

If you’re looking to revitalise your company’s marketing and boost your business success, there’s one tool that’s perfect for the job — call tracking software.

Read Full PostRead - Eye Icon
Using Promotional Gifts as a Customer Retention Strategy
Strategy
12/11/2025Using Promotional Gifts as a Customer Retention Strategy

In a culture filled with thumb taps, keyboard strokes, and tweets, marketing can sometimes feel like shouting into a black hole. Which is why when a customer can hold, feel, use, or show off your brand, they sit up and take notice. Promotional items are more t

Read Full PostRead - Eye Icon
Fossil Group, Inc. to Acquire Wearable Tech Innovator Misfit .
Finance
13/11/2015Fossil Group, Inc. to Acquire Wearable Tech Innovator Misfit .

Acquisition of Leading Technology Platform and World-Class Engineering Team Will Fuel Rapid Growth in Wearable Technology



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow